Recent studies of TLR5 activation as a strategy for treating allergic disease have used a TLR5 fusion protein conjugated with different allergens to explore the impact on T cell phenotype and downregulation of the Th2 response and the durability of the effect. This evidence concerns the gene TLR5 and allergic disease.